PDL BioPharma (PDLI)

PDL BioPharma Inc. (PDLI) CEO John McLaughlin on Q2 2018 Results - Earnings Call Transcript
Aug. 8, 2018 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q4 2017 Results - Earnings Call Transcript
March 8, 2018 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q3 2017 Results - Earnings Call Transcript
Nov. 2, 2017 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q2 2017 Results - Earnings Call Transcript
Aug. 4, 2017 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q1 2017 Results - Earnings Call Transcript
May 3, 2017 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q4 2016 Results - Earnings Call Transcript
March 1, 2017 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q3 2016 Results - Earnings Call Transcript
Nov. 3, 2016 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q2 2016 Results - Earnings Call Transcript
Aug. 7, 2016 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q1 2016 Results - Earnings Call Transcript
May 4, 2016 | Price: Free! | Source: Seeking Alpha

PDL BioPharma (PDLI) Q4 2015 Results - Earnings Call Webcast
Feb. 22, 2016 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q4 2015 Results - Earnings Call Transcript
Feb. 22, 2016 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q3 2015 Results - Earnings Call Transcript
Nov. 4, 2015 | Price: Free! | Source: Seeking Alpha

PDL BioPharma (PDLI) Q3 2015 Results - Earnings Call Webcast
Nov. 4, 2015 | Price: Free! | Source: Seeking Alpha

PDL BioPharma (PDLI) Q2 2015 Results - Earnings Call Webcast
Aug. 5, 2015 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q2 2015 Results - Earnings Call Transcript
Aug. 5, 2015 | Price: Free! | Source: Seeking Alpha

PDL BioPharma (PDLI) Q1 2015 Results - Earnings Call Webcast
May 6, 2015 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q1 2015 Results - Earnings call Transcript
May 6, 2015 | Price: Free! | Source: Seeking Alpha

PDL BioPharma (PDLI) Q4 2014 Results - Earnings Call Webcast
Feb. 23, 2015 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q4 2014 Results -- Earnings Call Transcript
Feb. 23, 2015 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q3 2014 Results - Earnings Call Transcript
Nov. 10, 2014 | Price: Free! | Source: Seeking Alpha

PDL BioPharma (PDLI) Q3 2014 Results - Earnings Call Webcast
Nov. 10, 2014 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q2 2014 Results - Earnings Call Transcript
Aug. 19, 2014 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q1 2014 Results - Earnings Call Transcript
May 12, 2014 | Price: Free! | Source: Seeking Alpha

PDL BioPharma, Inc. Discusses Q4 2013 Results (Webcast)
March 3, 2014 | Price: Free! | Source: Seeking Alpha

PDL BioPharma CEO Discusses Q4 2013 Results - Earnings Call Transcript
March 3, 2014 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's CEO Presents at Piper Jaffray 2013 Healthcare Conference (Transcript)
Dec. 3, 2013 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's CEO Presents at Jeffries 2013 Global Healthcare Conference (Transcript)
Nov. 21, 2013 | Price: Free! | Source: Seeking Alpha

PDL BioPharma at Credit Suisse Healthcare Conference Transcript
Nov. 13, 2013 | Price: $106.00 | Source: Thomson

PDL BioPharma's CEO Presents at Credit Suisse Healthcare Conference (Transcript)
Nov. 13, 2013 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's CEO Discusses Q3 2013 Results - Earnings Call Transcript
Nov. 6, 2013 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Q3 2013 Earnings Conference Call Transcript
Nov. 6, 2013 | Price: $106.00 | Source: Thomson

PDL BioPharma's CEO Discusses Q2 2013 Results - Earnings Call Transcript
Aug. 8, 2013 | Price: Free! | Source: Seeking Alpha

PDL BioPharma, Inc. Management Discusses Q2 2013 Results (Webcast)
Aug. 8, 2013 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Q2 2013 Earnings Conference Call Transcript
Aug. 8, 2013 | Price: $106.00 | Source: Thomson

PDL BioPharma CEO Presents at Goldman Sachs Healthcare Conference (Transcript)
June 11, 2013 | Price: Free! | Source: Seeking Alpha

PDL BioPharma at Goldman Sachs Healthcare Conference Transcript
June 11, 2013 | Price: $106.00 | Source: Thomson

PDL BioPharma at Jefferies Global Healthcare Conference Transcript
June 6, 2013 | Price: $106.00 | Source: Thomson

PDL BioPharma CEO Discuses Q1 2013 Results - Earnings Call Transcript
May 9, 2013 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Q1 2013 Earnings Conference Call Transcript
May 9, 2013 | Price: $106.00 | Source: Thomson

PDL BioPharma at Cowen Health Care Conference Transcript
March 6, 2013 | Price: $106.00 | Source: Thomson

PDL BioPharma's CEO Discusses Q4 2012 Results - Earnings Call Transcript
March 1, 2013 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Q4 2012 Earnings Conference Call Transcript
March 1, 2013 | Price: $106.00 | Source: Thomson

PDL BioPharma at RBC Capital Markets\' Healthcare Conference Transcript
Feb. 27, 2013 | Price: $106.00 | Source: Thomson

PDL BioPharma at JPMorgan Global Healthcare Conference Transcript
Jan. 10, 2013 | Price: $106.00 | Source: Thomson

PDL BioPharma's CEO Presents at 31st Annual JPMorgan Healthcare Conference (Transcript)
Jan. 10, 2013 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's CEO Presents at Lazard Capital Markets Healthcare Conference - Transcript
Nov. 13, 2012 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Q3 2012 Earnings Conference Call Transcript
Nov. 5, 2012 | Price: $106.00 | Source: Thomson

PDL BioPharma's CEO Discusses Q3 2012 Results - Earnings Call Transcript
Nov. 5, 2012 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's Management Presents at UBS Global Life Sciences Conference (Transcript)
Sept. 19, 2012 | Price: Free! | Source: Seeking Alpha

PDL BioPharma at UBS Global Life Sciences Conference Transcript
Sept. 19, 2012 | Price: $54.00 | Source: Thomson

PDL BioPharma at Think Equity Growth Conference Transcript
Sept. 13, 2012 | Price: $54.00 | Source: Thomson

PDL BioPharma at Rodman & Renshaw Global Investment Conference Transcript
Sept. 11, 2012 | Price: $54.00 | Source: Thomson

PDL BioPharma's CEO Discusses Q2 2012 Results - Earnings Call Transcript
Aug. 4, 2012 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Q2 2012 Earnings Conference Call Transcript
Aug. 2, 2012 | Price: $54.00 | Source: Thomson

PDL BioPharma President Presents at Goldman Sachs Annual Global Healthcare Conference (Transcript)
June 7, 2012 | Price: Free! | Source: Seeking Alpha

PDL BioPharma, Inc.(PDLI) Q1 2012 Earnings Call Transcript
May 3, 2012 | Price: Free! | Source: Morningstar

PDL BioPharma's CEO Discusses Q1 2012 Results - Earnings Call Transcript
May 3, 2012 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's CEO Discusses Q4 2011 Results - Earnings Call Transcript
Feb. 23, 2012 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's CEO Presents at 30th Annual JP Morgan Healthcare Conference (Transcript)
Jan. 12, 2012 | Price: Free! | Source: Seeking Alpha

PDL BioPharma's CEO Discusses Q3 2011 Results - Earnings Call Transcript
Nov. 9, 2011 | Price: Free! | Source: Seeking Alpha

PDL BioPharma, Inc.(PDLI) Q3 2011 Earnings Call Transcript
Nov. 9, 2011 | Price: Free! | Source: Morningstar

PDL Biopharma's CEO Discusses Q2 2011 Results - Earnings Call Transcript
July 27, 2011 | Price: Free! | Source: Seeking Alpha

PDL Biopharma's CEO Discusses Q1 2011 Results - Earnings Call Transcript
April 27, 2011 | Price: Free! | Source: Seeking Alpha

PDL BioPharma CEO Discusses Q4 2010 Results - Earnings Call Transcript
Feb. 28, 2011 | Price: Free! | Source: Seeking Alpha

PDL BioPharma CEO Discusses Q3 2010 Results – Earnings Call Transcript
Nov. 10, 2010 | Price: Free! | Source: Seeking Alpha

PDL BioPharma, Inc. Q2 2010 Earnings Call Transcript
July 28, 2010 | Price: Free! | Source: Seeking Alpha

PDL BioPharma, Inc. Q1 2010 Earnings Call Transcript
April 29, 2010 | Price: Free! | Source: Seeking Alpha

PDL BioPharma, Inc. Q4 2009 Earnings Call Transcript
March 2, 2010 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Q3 2009 Earnings Call Transcript
Oct. 28, 2009 | Price: Free! | Source: Seeking Alpha

PDL BioPharma, Inc. Q2 2009 Earnings Call Transcript
July 30, 2009 | Price: Free! | Source: Seeking Alpha

PDL BioPharma, Inc. Q1 2009 Earnings Call Transcript
May 7, 2009 | Price: Free! | Source: Seeking Alpha

PDL BioPharma, Inc. Q4 2008 Earnings Call Transcript
March 2, 2009 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Inc. Q3 2008 Earnings Call Transcript
Nov. 6, 2008 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Q2 2007 Earnings Call Transcript
Aug. 1, 2007 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Q1 2007 Earnings Call Transcript
May 2, 2007 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Q4 2006 Earnings Call Transcript
Feb. 21, 2007 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Q3 2006 Earnings Call Transcript
Nov. 3, 2006 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Inc. Q1 2006 Earnings Conference Call Transcript (PDLI)
May 3, 2006 | Price: Free! | Source: Seeking Alpha

PDL BioPharma Q4 2005 Earnings Conference Call Transcript (PDLI)
Feb. 28, 2006 | Price: Free! | Source: Seeking Alpha

Recent filings

Pdl Biopharma Names Edward Imbrogno Vice President Of Finance - Oct. 9, 2018

Departure of Directors or Certain - Oct. 4, 2018

Regulation FD - Oct. 2, 2018

Pdl Biopharma Announces New $100 Million Stock Repurchase Program - Sept. 24, 2018

Regulation FD - Sept. 5, 2018

PDL BioPharma Just Filed Its Quarterly Report: . Net Income (loss) ... - Aug. 9, 2018

PDL: Quarter 2018 Financial Results INCLINE VILLAGE, NV, ( - Aug. 8, 2018

Pdl Biopharma Acquires Depomed’S Remaining 50% Interest In Royalties And Milestones On Type 2 Diabetes Products - Aug. 2, 2018

PDL BioPharma director just declared 0 ownership of the company. - June 25, 2018

PDL BioPharma director just picked up 63,291 shares - June 25, 2018

Departure of Directors or Certain - June 14, 2018

PDL BioPharma director just picked up 54,348 shares - June 12, 2018

Vice President of PDL BioPharma was just granted 694,900 options - June 12, 2018

PDL BioPharma director just picked up 54,348 shares - June 12, 2018

PDL BioPharma director just picked up 54,348 shares - June 12, 2018

On June - June 12, 2018

PDL BioPharma director just picked up 54,348 shares - June 12, 2018

PDL BioPharma director just picked up 54,348 shares - June 12, 2018

PDL BioPharma director just picked up 54,348 shares - June 12, 2018

PDL BioPharma's CEO was just granted 1,922,100 options - June 12, 2018

PDL BioPharma director just picked up 54,348 shares - June 12, 2018

VP of PDL BioPharma was just granted 700,500 options - June 12, 2018

Shlomo Yanai Elected To Pdl Biopharma’S Board Of Directors - June 11, 2018

Regulation FD - June 8, 2018

Securities to be offered to employees in employee benefit plans - June 8, 2018

Regulation FD - May 22, 2018

Pdl Biopharma Names Dr. Jill Jene Vice President, Business Development - May 21, 2018

PDL: Cook Williams Communications, Inc - May 9, 2018

PDL: Cook Williams Communications, Inc - April 16, 2018

Regulation FD - April 10, 2018

Departure of Directors or Certain - April 9, 2018

Preliminary proxy statements, contested solicitations - April 9, 2018

PDL BioPharma Just Filed Its Annual Report: 3. Net Income per Sh... - March 16, 2018

Regulation FD - March 13, 2018

PDL: Cook Williams Communications, Inc - March 8, 2018

Regulation FD - Feb. 21, 2018

Pdl Biopharma Terminates Interest In Pursuing Acquisition Of Neos - Feb. 20, 2018

Renaissance Technologies LLC just provided an update on share ownership of PDL BioPharma - Feb. 14, 2018

STATE STREET CORPORATION just provided an update on share ownership of PDL BioPharma - Feb. 14, 2018

The Vanguard Group just provided an update on share ownership of PDL BioPharma - Feb. 9, 2018

BlackRock, Inc. just provided an update on share ownership of PDL BioPharma - Jan. 23, 2018

Departure of Directors or Certain - Dec. 21, 2017

PDL BioPharma's CEO just disposed of 151,678 shares - Dec. 19, 2017

VP of PDL BioPharma just disposed of 17,959 shares - Dec. 19, 2017

VP of PDL BioPharma just disposed of 5,513 shares - Dec. 19, 2017

Vice President of PDL BioPharma just disposed of 17,818 shares - Dec. 19, 2017

Current report, items 7.01 and 9.01 - Nov. 14, 2017

PDL BioPharma Just Filed Its Quarterly Report: 2. Net Income per Sh... - Nov. 13, 2017

Notification of inability to timely file Form 10-Q or 10-QSB - Nov. 13, 2017

Pdl Biopharma’S Proposal To Acquire Neos Therapeutics Expires Today; - Nov. 8, 2017

PDL: Cook Williams Communications, Inc - Nov. 2, 2017

Pdl Biopharma Issues Statement In Response To Neos Therapeutics Rejection Of Pdl Acquisition Proposal INCLINE VILLAGE, NV - Oct. 30, 2017

PDL: Cook Williams Communications, Inc - Oct. 30, 2017

Pdl Biopharma Proposes To Acquire Neos Therapeutics For $10.25 Per Share In Cash - Oct. 26, 2017

Departure of Directors or Certain - Oct. 12, 2017

Current report, items 7.01, 8.01, and 9.01 - Sept. 25, 2017

Completion of Acquisition or Disposition of - Sept. 21, 2017

PDL BioPharma's President just picked up 240,200 shares - Sept. 13, 2017

PDL BioPharma's President just declared 0 ownership of the company. - Sept. 13, 2017

Securities to be offered to employees in employee benefit plans - Sept. 12, 2017

PDL: Cook Williams Communications, Inc - Sept. 11, 2017

Current report, items 7.01 and 9.01 - Sept. 11, 2017

Securities to be offered to employees in employee benefit plans - Sept. 7, 2017

PDL: Cook Williams Communications, Inc - Aug. 3, 2017

PDL BioPharma Just Filed Its Quarterly Report: 2. Net Income per Sh... - Aug. 3, 2017

PDL BioPharma director just picked up 60,729 shares - June 12, 2017

PDL BioPharma director just picked up 60,729 shares - June 12, 2017

Termination of a Material Definitive - June 12, 2017

PDL BioPharma director just picked up 60,729 shares - June 12, 2017

Submission of Matters to a Vote of Security - June 12, 2017

PDL BioPharma director just picked up 60,729 shares - June 12, 2017

PDL BioPharma director just picked up 60,729 shares - June 12, 2017

PDL BioPharma director just picked up 60,729 shares - June 12, 2017

Current report, items 7.01 and 9.01 - June 7, 2017

PDL: Cook Williams Communications, Inc - June 5, 2017

And Pdl Biopharma Complete Strategic Financial RESTRUCTURING OF LENSAR - May 11, 2017

PDL BioPharma Just Filed Its Quarterly Report: 2. Net Income per Sh... - May 3, 2017

Additional definitive proxy soliciting materials and Rule 14(a)(12) material - April 28, 2017

PDL BioPharma releases salary data. CEO sees compensation rise 7% - April 28, 2017

PDL: Cook Williams Communications, Inc - April 6, 2017

Vice President of PDL BioPharma just picked up 25,000 shares - March 27, 2017

On March - March 21, 2017

On March - March 14, 2017

Departure of Directors or Certain - March 10, 2017

On March - March 8, 2017

PDL BioPharma's Controller and CAO just picked up 98,039 shares - March 7, 2017

VP of PDL BioPharma just picked up 214,372 shares - March 7, 2017

Vice President of PDL BioPharma just picked up 212,669 shares - March 7, 2017

President of PDL BioPharma just picked up 588,235 shares - March 7, 2017

PDL BioPharma's VP Business Development just picked up 199,019 shares - March 7, 2017

PDL: Cook Williams Communications, Inc - March 1, 2017

PDL: Cook Williams Communications, Inc - March 1, 2017

PDL BioPharma Just Filed Its Annual Report: 3. Net Income per Sh... - March 1, 2017

On February 21 and - Feb. 21, 2017

Renaissance Technologies LLC just provided an update on share ownership of PDL BioPharma - Feb. 14, 2017

The Vanguard Group just provided an update on share ownership of PDL BioPharma - Feb. 10, 2017

First Trust Portfolios L.P. just provided an update on share ownership of PDL BioPharma - Jan. 31, 2017

BlackRock, Inc. just provided an update on share ownership of PDL BioPharma - Jan. 25, 2017

Beginning on January - Jan. 9, 2017

Entry into a Material Definitive - Dec. 20, 2016

Sorry, no schedule available for this company

Owner Shares% of PortfolioAs Of
1. LINDEN ADVISORS LP 27,867,000 0.8 Dec. 31, 2017
2. Citadel Advisors LLC 22,393,160 N/A Sept. 30, 2017
3. Whitebox Advisors LLC 22,181,000 0.8 June 30, 2018
4. WOLVERINE ASSET MANAGEMENT LLC 16,852,000 0.1 June 30, 2018
5. Pinnacle Summer Investments, Inc. 16,672,546 0.1 Dec. 31, 2015
6. VANGUARD GROUP INC 13,064,740 N/A Dec. 31, 2017
7. DIMENSIONAL FUND ADVISORS LP 12,514,490 N/A June 30, 2018
8. First Trust Portfolios L.P. 10,709,055 N/A Oct. 31, 2015
9. RENAISSANCE TECHNOLOGIES LLC 9,648,854 N/A June 30, 2018
10. State Street Corp 8,216,760 N/A June 30, 2018
11. Context Capital Management, LLC 8,175,000 6.3 June 30, 2018
12. DEUTSCHE BANK AG\ 7,975,977 N/A June 30, 2018
13. BlackRock Fund Advisors 6,401,415 N/A Sept. 30, 2016
14. DEUTSCHE BANK AG\ 5,941,820 N/A Dec. 31, 2017
15. BlackRock Institutional Trust Company, N.A. 5,819,729 N/A Dec. 31, 2016
16. Connor, Clark & Lunn Investment Management Ltd. 5,677,647 0.1 June 30, 2018
17. AQR CAPITAL MANAGEMENT LLC 5,358,325 N/A Dec. 31, 2017
18. OAKTREE CAPITAL MANAGEMENT LP 5,060,000 0.1 June 30, 2018
19. CNH PARTNERS LLC 5,000,000 0.1 Dec. 31, 2017
20. NORTHERN TRUST CORP 4,973,948 N/A March 31, 2018
21. Man Investments (CH) AG 4,500,000 2.6 June 30, 2017
22. ACADIAN ASSET MANAGEMENT LLC 3,999,658 N/A June 30, 2018
23. SCHWAB CHARLES INVESTMENT MANAGEMENT INC 3,575,598 N/A June 30, 2018
24. MILLENNIUM MANAGEMENT LLC 3,520,598 N/A Sept. 30, 2017
25. MORGAN STANLEY 3,492,068 N/A Dec. 31, 2016
26. KENNEDY CAPITAL MANAGEMENT, INC. 2,760,376 0.1 June 30, 2018
27. ZAZOVE ASSOCIATES LLC 2,651,000 0.1 Dec. 31, 2017
28. Russell Frank Co/ 2,511,507 N/A Sept. 30, 2015
29. D. E. Shaw & Co., Inc. 2,337,141 N/A June 30, 2018
30. Sage Capital Management, LLC 2,044,000 N/A Sept. 30, 2015

PDL BioPharma (PDLI)

140
 


Feedback